Main Profile

At A Glance

Dream Team targets molecular factors common in women's cancers

First clinical trials begin soon to test new drugs against ovarian, endometrial and breast cancers that harbor dysfunctional PI3K pathways. MD Anderson's Gordon Mills explains.
Length: 04:07

Contact

Questions about Dream Team targets molecular factors common in women's cancers

Want more info about Dream Team targets molecular factors common in women's cancers? Get free advice from education experts and Noodle community members.

  • Answer

Ask a New Question